COURT-RULING ·Filed Jun 29, 2026

ELAN

Elanco Animal Health Inc
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago CourtView Ruling on CourtListener
Court ruling (appellate)
Actionable Insight • Neutral

The ruling removes a small litigation overhang. No material financial impact expected. Monitor for any Supreme Court cert petition, though unlikely given the case's narrow scope.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
ELAN ▼ -7.32% at T+60d
NEUTRAL call ✗ call lost -7.32% · α vs SPY -11.69% · entry $24.74 → $22.93
Entry anchored
Jun 26, 03:59 PM ET
via exchange tick
T+1d
-0.53%
call -0.53% · α -1.30%
$24.61
settled 3mo ago
T+5d
+1.58%
call +1.58% · α +0.19%
$25.13
settled 3mo ago
T+20d
+0.69%
call +0.69% · α +0.97%
$24.91
settled 2mo ago
T+60d
-7.32%
call -7.32% · α -11.69%
$22.93
settled 10d ago

Price Chart

Loading chart...

Executive Summary

The Seventh Circuit affirmed summary judgment for Elanco in a class action alleging violations of the Indiana Wage Payment Statute. The court held that Elanco's vacation buy program did not constitute an assignment of wages and that unused COVID-19 carryover vacation hours were not payable upon termination. This ruling eliminates a minor litigation overhang with no material financial impact.

Court Ruling Details

Ruling Date
Jun 29, 2026
Court
Court of Appeals for the Seventh Circuit
Court Level
Appellate
Judge
Easterbrook
Case Type
employment
Ruling Type
final judgment
Outcome
WIN — ruling favors this company
Will It Be Appealed?
Unlikely
Precedent Risk
LOW

Key Facts

  • Seventh Circuit affirmed district court's summary judgment for Elanco in a class action under the Indiana Wage Payment Statute.
  • The court ruled that the vacation buy program was a salary reduction, not an assignment of wages, and thus not subject to statutory writing requirements.
  • Elanco was not required to pay for unused COVID-19 carryover vacation hours upon termination.
  • The opinion noted that the putative class was limited to Indiana employees and the potential exposure was small.

Financial Impact

No damages awarded; potential liability eliminated was trivial relative to Elanco's $12.3B market cap.

Risk Factors

  • None material; the ruling is final and favorable to Elanco.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-2cqpwwtf-ELAN
13 reports for ELAN
Performance horizon
78% Hit rate 7 of 9 directional calls best @ T+5▲ +15.03%May 19, 2026
Filters
Rows
Reports for ELAN — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Press Release
BULLISH ★ 6/10
$23.17 $22.42▼ −3.24%▼ −3.02%$22.14 (−4.45%)
Aug 21, 2026
6w ago
Insider Cluster
BULLISH ★ 6/10
$23.97 $24.11▲ +0.58%▲ +0.11%$22.14 (−7.63%)
Aug 21, 2026
6w ago
Insider Cluster
BULLISH ★ 4/10
$23.97 $24.11▲ +0.58%▲ +0.11%$22.14 (−7.63%)
Aug 18, 2026
6w ago
Insider Cluster
BULLISH ★ 4/10
$23.63 $25.09▲ +6.19%▲ +6.39%$22.14 (−6.30%)
Aug 13, 2026
7w ago
Insider Cluster
BULLISH ★ 4/10
$22.51 $23.56▲ +4.66%▲ +6.63%$22.14 (−1.64%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$22.73 $23.64▲ +4.00%▲ +4.41%$22.14 (−2.60%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$26.22 $22.04▼ −15.95%▼ −16.30%$22.14 (−15.56%)
Jun 29, 2026
13w ago
Court Ruling
NEUTRAL ★ 2/10
$24.74 $25.13▲ +1.58%▲ +0.19%$22.14 (−10.51%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$23.61 $24.58▲ +4.11%▲ +3.64%$22.14 (−6.22%)
May 19, 2026
19w ago
Insider Cluster
BULLISH ★ 4/10
$20.83 $23.69▲ +13.74%▲ +12.50%$22.14 (+6.30%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (64h 20m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access